Feng Q, Sun Y, Yang Z, Wang Z, Chen Z, Liu F
Front Oncol. 2025; 14():1522919.
PMID: 39850821
PMC: 11754209.
DOI: 10.3389/fonc.2024.1522919.
Wei Y, Xu Y, Sun Q, Hong Y, Liang S, Jiang H
Int J Biol Sci. 2024; 20(12):4674-4690.
PMID: 39309434
PMC: 11414377.
DOI: 10.7150/ijbs.96476.
Zheng H, Wu R, Zhang G, Wang Q, Li Q, Zhang L
Clin Transl Oncol. 2024; 27(2):449-457.
PMID: 39083141
DOI: 10.1007/s12094-024-03589-z.
Jin X, Qin Z, Zhao H
BMC Immunol. 2024; 25(1):51.
PMID: 39068393
PMC: 11282667.
DOI: 10.1186/s12865-024-00639-7.
Jin X, Chen Z, Zhao H
Front Oncol. 2024; 14:1288820.
PMID: 38841168
PMC: 11150821.
DOI: 10.3389/fonc.2024.1288820.
Fluoride Induces Neurocytotoxicity by Disrupting Lysosomal Iron Metabolism and Membrane Permeability.
Xu P, Xing H, Ma Y, Ding X, Li T, Zhang Y
Biol Trace Elem Res. 2024; 203(2):835-849.
PMID: 38760610
DOI: 10.1007/s12011-024-04226-0.
Cuproptosis in glioblastoma: unveiling a novel prognostic model and therapeutic potential.
Qin Z, Yang B, Jin X, Zhao H, Liu N
Front Oncol. 2024; 14:1359778.
PMID: 38606090
PMC: 11007140.
DOI: 10.3389/fonc.2024.1359778.
Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas.
Onciul R, Brehar F, Toader C, Covache-Busuioc R, Glavan L, Bratu B
Curr Issues Mol Biol. 2024; 46(3):2402-2443.
PMID: 38534769
PMC: 10969338.
DOI: 10.3390/cimb46030153.
SMG9 is a novel prognostic-related biomarker in glioma correlating with ferroptosis and immune infiltrates.
Dai Y, Zhang H, Feng S, Guo C, Tian W, Sun Y
Heliyon. 2024; 10(4):e25716.
PMID: 38384572
PMC: 10878878.
DOI: 10.1016/j.heliyon.2024.e25716.
Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
Yan J, Fang Z, Shi M, Tu C, Zhang S, Jiang C
J Cancer. 2024; 15(4):1053-1066.
PMID: 38230212
PMC: 10788733.
DOI: 10.7150/jca.91796.
A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family.
Fu D, Zhang X, Zhou Y, Hu S
BMC Med Genomics. 2024; 17(1):16.
PMID: 38191397
PMC: 10775544.
DOI: 10.1186/s12920-023-01789-0.
Copper Homeostasis Based on Cuproptosis-Related Signature Optimizes Molecular Subtyping and Treatment of Glioma.
Zhang S, Yu H, Sun S, Fan X, Bi W, Li S
Mol Neurobiol. 2023; 61(8):4962-4975.
PMID: 38151613
DOI: 10.1007/s12035-023-03893-9.
A Genome-Wide Interaction Study of Erythrocyte ω-3 Polyunsaturated Fatty Acid Species and Memory in the Framingham Heart Study Offspring Cohort.
Annevelink C, Westra J, Sala-Vila A, Harris W, Tintle N, Shearer G
J Nutr. 2023; 154(5):1640-1651.
PMID: 38141771
PMC: 11347816.
DOI: 10.1016/j.tjnut.2023.12.035.
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y, Wu X, Zhu J, Lu R, Ouyang Y
BMC Cancer. 2023; 23(1):1120.
PMID: 37978473
PMC: 10655456.
DOI: 10.1186/s12885-023-11637-0.
Transcriptomic Characterization of Copper-Binding Proteins for Predicting Prognosis in Glioma.
Zeng H, Li H, Yang Q, Li C
Brain Sci. 2023; 13(10).
PMID: 37891828
PMC: 10605646.
DOI: 10.3390/brainsci13101460.
The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies.
Xi Y, Gao L, Li S, Sun K, Chen P, Cai Z
Front Pharmacol. 2023; 14:1228985.
PMID: 37818196
PMC: 10560744.
DOI: 10.3389/fphar.2023.1228985.
The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J, Xu Z, Fan Q, Sun Y, Lin X
Front Mol Neurosci. 2023; 16:1198713.
PMID: 37501725
PMC: 10369193.
DOI: 10.3389/fnmol.2023.1198713.
Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
Zhao Z, Sun C, Hou J, Yu P, Wei Y, Bai R
J Ovarian Res. 2023; 16(1):126.
PMID: 37386521
PMC: 10308644.
DOI: 10.1186/s13048-023-01218-x.
Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma.
Ju M, Jang E, Kang S, Roh Y, Jeong J, Han S
J Hepatocell Carcinoma. 2023; 10:643-658.
PMID: 37101765
PMC: 10124562.
DOI: 10.2147/JHC.S394973.
High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma.
Deng L, Zeng S, Yi Q, Song L
PeerJ. 2023; 11:e15136.
PMID: 37009153
PMC: 10065001.
DOI: 10.7717/peerj.15136.